Pages

▼
Monday, October 9, 2023

DFMO Starts A Phase-II Clinical Trial (TADPOL)

›
Difluoromethylornithine (DFMO), also known as Eflornithine, is FDA approved since 1990 as an injection to treat African Sleeping Sickness (t...
Wednesday, September 20, 2023

Strong Results from a Pilot Study of Semaglutide in Adult Honeymooners

›
I've been blogging on research aimed at curing type-1 diabetes for over 15 years, and in that entire time, rarely have I rushed to blog ...
1 comment:
Monday, July 31, 2023

T1D Research News (Quick Bits for July)

›
This blog is a collection of smaller news items about T1D. COVID Not Likely to Increase T1D in Children From the beginning of COVID there ha...
Monday, June 12, 2023

CELZ-201 Starts a Phase-I Trial (CREATE-1)

›
CELZ-201 is a stem cell product, where the cells are isolated from the umbilical cord, Wharton’s jelly, placenta, amniotic membrane, and/or ...
Tuesday, May 9, 2023

Dompé Starts GLADIATOR, a Phase-III Clinical Trial of Ladarixin

›
Ladarixin is a drug being develop by Dompé (an Italian company).  It inhibits activity on parts of the immune system called the IL-8 recepto...
1 comment:
Friday, April 7, 2023

T1D Research News (Quick Bits from April)

›
This blog covers three pieces of news which do not apply directly to cure focused research, but which I found interesting anyway. Tight Hone...
Friday, March 31, 2023

Results from a Phase-II Verapamil Study

›
Verapamil is a drug which has been used in the US since 1982 for high blood pressure, migraines, and heart problems.  It also lowers levels ...